Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to establish the safety of ezetimibe/simvastatin and simvastatin
in adolescents with Type 1 Diabetes and to determine the amount of decrease in
LDL-cholesterol.The study hypothesizes that simvastatin and ezetimibe/simvastatin will be
safe in adolescents with Type 1 Diabetes and will lower LDL-cholesterol at 6 months.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Merck Sharp & Dohme Corp. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin